- Home
- BTSG vs NEO Comparison
BTSG vs NEO Comparison
Compare BTSG & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTSG
- NEO
- Stock Information
- Founded
- BTSG 1974
- NEO 2001
- Country
- BTSG United States
- NEO United States
- Employees
- BTSG N/A
- NEO N/A
- Industry
- BTSG
- NEO Precision Instruments
- Sector
- BTSG
- NEO Health Care
- Exchange
- BTSG NYSE
- NEO Nasdaq
- Market Cap
- BTSG 2.0B
- NEO 1.9B
- IPO Year
- BTSG 2024
- NEO 1999
- Fundamental
- Price
- BTSG $18.75
- NEO $15.39
- Analyst Decision
- BTSG Strong Buy
- NEO Strong Buy
- Analyst Count
- BTSG 12
- NEO 8
- Target Price
- BTSG $16.86
- NEO $20.25
- AVG Volume (30 Days)
- BTSG 1.5M
- NEO 722.4K
- Earning Date
- BTSG 11-01-2024
- NEO 11-05-2024
- Dividend Yield
- BTSG N/A
- NEO N/A
- EPS Growth
- BTSG N/A
- NEO N/A
- EPS
- BTSG N/A
- NEO N/A
- Revenue
- BTSG $10,588,215,000.00
- NEO $644,118,000.00
- Revenue This Year
- BTSG $28.69
- NEO $12.93
- Revenue Next Year
- BTSG $10.47
- NEO $9.70
- P/E Ratio
- BTSG N/A
- NEO N/A
- Revenue Growth
- BTSG 25.72
- NEO 12.06
- 52 Week Low
- BTSG $7.85
- NEO $12.77
- 52 Week High
- BTSG $20.25
- NEO $21.22
- Technical
- Relative Strength Index (RSI)
- BTSG 60.55
- NEO 56.48
- Support Level
- BTSG $18.27
- NEO $14.81
- Resistance Level
- BTSG $19.90
- NEO $16.60
- Average True Range (ATR)
- BTSG 0.76
- NEO 0.67
- MACD
- BTSG -0.08
- NEO 0.01
- Stochastic Oscillator
- BTSG 59.91
- NEO 62.77
About BTSG BRIGHTSPRING HEALTH SERVICES INC
BrightSpring Health Services Inc is a home and community-based healthcare services platform, focused on delivering complementary pharmacy and provider services to complex patients. Its platform delivers clinical services and pharmacy solutions across Medicare, Medicaid, and commercially insured populations. Its segments include Pharmacy Solutions, Provider Service. and others. It generates the majority of its revenue from the Pharmacy Solutions segment.
About NEO NeoGenomics Inc.
NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Advanced Diagnostics. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. Advanced Diagnostics segment supports pharmaceutical firms in their drug development programs by supporting various clinical trials and research. For Clinical Services, Its specialized diagnostic services are performed based on an online test order or a written test requisition form. The company generates majority of its revenue from Clinical Services.